KRAS and breast cancer: Parallel to that, here, we identified differences in intracellular Ca2+ response after ATP-activated P2Y2 receptor signaling in metastatic breast cancer cells with oncogenic KRas mutations compared to non-malignant breast epithelial cells (Figure 2).